Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Bruce Sands
Icahn School of Medicine at Mount Sinai, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
AbbVie, Inc.
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Bruce Sands (a Mentor in this study and Chief of the Henry D. Janowitz Division of Gastroenterology) receives financial compensation as a consultant for companies which develop or assess medicines used for the treatment of inflammatory bowel disease (IBD).
IBDPROMISE: A Web-based Patient-centric Model to Improve Quality and Outcomes
Measuring and improving healthcare quality is an important national challenge. Improvement cannot be achieved if patients are not made aware of care quality that they are receiving, hence we are providing electronic Quality Report Cards to patients and providers that will bring discussion about quality and outcomes at the forefront of care and help improve patient outcomes.
Filed on November 02, 2017.
Tell us what you know about Bruce Sands's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Bruce Sands”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Bruce Sands | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Janssen Biotech | $5,000 - $9,999 |
| Bruce Sands | Icahn School of Medicine at Mount Sinai | Conflict of Interest | AbbVie | $10,000 - $19,999 |
| Bruce Sands | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Shire | $5,000 - $9,999 |
| Bruce Sands | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Janssen Research and D& Development | $5,000 - $9,999 |
| Bruce Sands | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Takeda Pharmaceutical Company Limited | $5,000 - $9,999 |
| Bruce Sands | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Allergan, Inc. | $5,000 - $9,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.